Phaseline

Targets › ACTH

ACTH: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Immunology; next expected readout Aug 2027.

Open in Phaseline: the race on ACTH, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Massachusetts General HospitalPurified Cortrophin Gel
Adrenocorticotropic hormone (ACTH) analog
ACTHPhase 4Gout ArthritisAug 2027

Conditions

Gout Arthritis (1)

Modalities

small molecule (1)

Companies

Massachusetts General Hospital (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.